Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SLS

SELLAS Life Sciences Group Inc

May 13 • 04:00PM ET

6.53

+1.31 25.10 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: XNCR RCUS FATE KURA ADCT

| Held by: XBI IWM VTI VXF IWO VTWO VFMO IWC PTH DWAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.23	Insider Own	1.27%	Shs Outstand	181.33M	Perf Week	26.80%
Market Cap	1.17B	Forward P/E	-	EPS next Y	-0.15	Insider Trans	2.86%	Shs Float	177.31M	Perf Month	34.36%
Enterprise Value	1.07B	PEG	-	EPS next Q	-0.05	Inst Own	25.48%	Short Float	32.23%	Perf Quarter	77.93%
Income	-29.46M	P/S	-	EPS this Y	16.00%	Inst Trans	3.04%	Short Ratio	9.20	Perf Half Y	335.33%
Sales	0.00M	P/B	11.02	EPS next Y	28.57%	ROA	-39.50%	Short Interest	57.15M	Perf YTD	73.21%
Book/sh	0.59	P/C	10.94	EPS next 5Y	50.68%	ROE	-43.58%	52W High	6.14 6.35%	Perf Year	363.12%
Cash/sh	0.60	P/FCF	-	EPS past 3/5Y	51.28% 34.92%	ROIC	-27.35%	52W Low	1.36 380.15%	Perf 3Y	329.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.41% 5.64%	Perf 5Y	-14.19%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	54.32%	Oper. Margin	-	ATR (14)	0.40	Perf 10Y	-99.98%
Dividend Ex-Date	Mar 24, 2011	Quick Ratio	17.22	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	72.29	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	17.22	EPS Q/Q	26.44%	SMA20	30.16%	Beta	2.26	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	30.83%	Rel Volume	4.90	Prev Close	5.22
Employees	13	LT Debt/Eq	0.00	Earnings	May 12 AMC	SMA200	110.14%	Avg Volume	6.21M	Price	6.53
IPO	Mar 12, 2008	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.67% -	Trades		Volume	30,438,495	Change	25.10%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)